Upregulation of PPARα and its target genes in patients with NASH at baseline was correlated with a significant downregulation of inflammatory response genes, as well as that of lipogenesis genes in responders to fibrate treatment49. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.